The predictive value of the HALP score for no-reflow phenomenon and short-term mortality in patients with ST-elevation myocardial infarction
Objective ST-elevation myocardial infarction (STEMI) is a medical emergency demanding
immediate intervention, and primary percutaneous coronary intervention (pPCI) is the …
immediate intervention, and primary percutaneous coronary intervention (pPCI) is the …
HbA1c/C-Peptide ratio is a potential biomarker used to predict No-reflow phenomenon in patients with ST-elevation myocardial infarction
DG Mo, MM Wang - Angiology, 2023 - journals.sagepub.com
HbA1c/C-Peptide Ratio Is a Potential Biomarker Used to Predict No-Reflow Phenomenon in
Patients With ST-Elevation Myocardial Infarction - De-Gang Mo, Meng-Meng Wang, 2023 Skip …
Patients With ST-Elevation Myocardial Infarction - De-Gang Mo, Meng-Meng Wang, 2023 Skip …
The triglyceride–glucose index is associated with no-reflow phenomenon in STEMI patients with type 2 diabetes after percutaneous coronary intervention
J Ma, P Wu, S Ma, X Ma, P Jin, S Jia - Frontiers in Cardiovascular …, 2024 - frontiersin.org
Background The relationship between the triglyceride–glucose (TyG) index and no-reflow
phenomenon after percutaneous coronary intervention (PCI) in patients with type 2 diabetes …
phenomenon after percutaneous coronary intervention (PCI) in patients with type 2 diabetes …
The association between HbA1c/C-peptide levels and short-term mortality in patients diagnosed with myocardial infarction
SE Ömür, E Koyun, G Cabri, Ç Zorlu - Biomarkers in Medicine, 2024 - Taylor & Francis
Introduction: In this study, we aimed to investigate the effect of HbA1C/C-peptide ratio on
short-term mortality (this period is defined as 30 days after diagnosis) in the patients with …
short-term mortality (this period is defined as 30 days after diagnosis) in the patients with …
Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction
Dear editor, We thank Mo et al., 1 for their constructive suggestions regarding our article
entitled “The HbA1c/C-Peptide Ratio Is Associated With the No-Reflow Phenomenon in …
entitled “The HbA1c/C-Peptide Ratio Is Associated With the No-Reflow Phenomenon in …
Does the eosinophil-to-monocyte ratio predict inflammation in patients with diabetic retinopathy: Diabetic retinopathy and Eosinophil-to-monocyte ratio
S Usalp - International Journal of Current Medical and Biological …, 2024 - ijcmbs.com
Backgruond: Our purpose is to investigate the demographic, clinical and haematological
parameters of patients diagnosed with diabetic retinopathy (DRP) without coronary artery …
parameters of patients diagnosed with diabetic retinopathy (DRP) without coronary artery …